Osborne Clarke has advised neuroClues®. neuroClues®, a European MedTech company powered by P3Lab SRL, has completed a €10 million Series A investment round. The funding round...
neuroClues® Secures €10 Million in Series A Fundraising for AI-Powered Neurological Biomarkers Expansion
TechWolf’s Financing Round With HSBC
Osborne Clarke advised HSBC on investment in AI-powered workforce management provider TechWolf. HSBC has made a strategic investment in TechWolf, a leading provider of AI-driven talent...
Sunrise’s €17 Million Fundraising
Osborne Clarke has advised Sunrise. Sunrise recently raised €17 million to support the roll out of their ground-breaking sleep research in Europe and the American market. Sunrise’s...
Bolt’s Expansion Into Belgium
Osborne Clarke has advised mobility platform Bolt on its recent expansion into Belgium. Bolt, which launched in Tallinn in 2013 and expanded into Belgium in 2021...
Euroclear’s Investment in Greenomy
Osborne Clarke has assisted in the latest investment in Greenomy. Euroclear, a Belgium-based global provider of Financial Market Infrastructure (FMI) services, is the investor. The investment...
Dentons Global Advisors’ Acquisition Of Interel
Osborne Clarke has advised Interel on the deal. Interel, an award-winning pan-European public affairs consultancy, has been acquired by Dentons Global Advisors. Interel has offices in...
Catalent’s Acquisition Of Delphi Genetics
Osborne Clarke has advised Delphi Genetics on the deal. Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based...